Long noncoding RNAs in digestive system cancers: Functional roles, molecular mechanisms, and clinical implications (Review)

被引:31
作者
Fu, Min [1 ,2 ]
Zou, Chen [1 ]
Pan, Lei [1 ]
Liang, Wei [2 ]
Qian, Hui [2 ]
Xu, Wenrong [2 ]
Jiang, Pengcheng [1 ]
Zhang, Xu [2 ]
机构
[1] Jiangsu Univ, Affiliated Peoples Hosp, Dept Gen Surg, 8 Dianli Rd, Zhenjiang 212002, Jiangsu, Peoples R China
[2] Jiangsu Univ, Sch Med, Jiangsu Key Lab Med Sci & Lab Med, 301 Xuefu Rd, Zhenjiang 212013, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
long noncoding RNA; digestive system cancer; biomarker; target; therapy; PROMOTES CELL-PROLIFERATION; HEPATOCELLULAR-CARCINOMA CELLS; TO-MESENCHYMAL TRANSITION; GASTRIC-CANCER; POOR-PROGNOSIS; DOWN-REGULATION; COLORECTAL-CANCER; UP-REGULATION; COLON-CANCER; MALAT1; PROMOTES;
D O I
10.3892/or.2016.4929
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Long noncoding RNAs (lncRNAs) are emerging as new players in various diseases including cancer. LncRNAs have been shown to play multifaceted roles in the development, progression, and metastasis of cancer. In this review, we highlight the lncRNAs that are critically involved in the pathogenesis of digestive system cancers (DSCs). We summarize the roles of the lncRNAs in DSCs and the underlying mechanisms responsible for their functions. The DSC-associated lncRNAs interact with a wide spectrum of molecules to regulate gene expression at transcriptional, post-transcriptional, and translational levels. We also provide new insights into the clinical significance of these lncRNAs, which are found to be closely associated with the aggressiveness of DSCs and could predict the prognosis of DSC patients. Moreover, lncRNAs have been suggested as promising therapeutic targets in DSCs. Therefore, better understanding of the functional roles of lncRNAs will provide new biomarkers for DSC diagnosis, prognosis, and therapy.
引用
收藏
页码:1207 / 1218
页数:12
相关论文
共 154 条
[1]   Differential expression of colon cancer associated transcript1 (CCAT1) along the colonic adenoma-carcinoma sequence [J].
Alaiyan, Bilal ;
Ilyayev, Nadia ;
Stojadinovic, Alexander ;
Izadjoo, Mina ;
Roistacher, Marina ;
Pavlov, Vera ;
Tzivin, Victoria ;
Halle, David ;
Pan, Honguang ;
Trink, Barry ;
Gure, Ali O. ;
Nissan, Aviram .
BMC CANCER, 2013, 13
[2]  
[Anonymous], BIOMED RES INT
[3]  
[Anonymous], BIOMED RES INT
[4]   Loss of DNA methylation at imprinted loci is a frequent event in hepatocellular carcinoma and identifies patients with shortened survival [J].
Anwar, Sumadi Lukman ;
Krech, Till ;
Hasemeier, Britta ;
Schipper, Elisa ;
Schweitzer, Nora ;
Vogel, Arndt ;
Kreipe, Hans ;
Lehmann, Ulrich .
CLINICAL EPIGENETICS, 2015, 7
[5]  
Arita T, 2013, ANTICANCER RES, V33, P3185
[6]   Possible physiological role of H19 RNA [J].
Ayesh, S ;
Matouk, I ;
Schneider, T ;
Ohana, P ;
Laster, M ;
Al-Sharef, W ;
de-Groot, N ;
Hochberg, A .
MOLECULAR CARCINOGENESIS, 2002, 35 (02) :63-74
[7]   The large non-coding RNA ANRIL, which is associated with atherosclerosis, periodontitis and several forms of cancer, regulates ADIPOR1, VAMP3 and C11ORF10 [J].
Bochenek, Gregor ;
Haesler, Robert ;
El Mokhtari, Nour-Eddine ;
Koenig, Inke R. ;
Loos, Bruno G. ;
Jepsen, Soeren ;
Rosenstiel, Philip ;
Schreiber, Stefan ;
Schaefer, Arne S. .
HUMAN MOLECULAR GENETICS, 2013, 22 (22) :4516-4527
[8]  
Bosman FT, 2010, WHO Classification of tumors of the digestive system, V4th
[9]   microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer [J].
Braconi, C. ;
Kogure, T. ;
Valeri, N. ;
Huang, N. ;
Nuovo, G. ;
Costinean, S. ;
Negrini, M. ;
Miotto, E. ;
Croce, C. M. ;
Patel, T. .
ONCOGENE, 2011, 30 (47) :4750-4756
[10]   RNA-Based Therapeutics: Current Progress and Future Prospects [J].
Burnett, John C. ;
Rossi, John J. .
CHEMISTRY & BIOLOGY, 2012, 19 (01) :60-71